ACE |
Angiotensin-converting enzyme |
AF |
Atrial fibrillation |
Ang II |
Angiotensin II |
ARB |
Angiotensin receptor blocker |
ARVC |
Arrhythmogenic right ventricular cardiomyopathy |
ATAC-seq |
Assay for Transposase-Accessible Chromatin-sequencing |
ATM |
Ataxia telangiectasia mutated |
BET |
Bromodomain and extra-terminal motif |
BRD |
Bromodomain |
CF |
Cardiac fibroblast |
CpG |
Cytosine-phosphodiester bond-guanine |
CVD |
Cardiovascular disease |
DAMPS |
Damage-associated molecular patterns |
DCM |
Dilated cardiomyopathy |
DDR |
DNA damage response |
DNMT |
DNA methyltransferase |
ECM |
Extracellular matrix |
FDA |
Food and Drug Administration |
HAT |
Histone acetyltransferase |
HCM |
Hypertrophic cardiomyopathy |
HDAC |
Histone deacetylase |
HDM |
Histone demethylase |
HF |
Heart failure |
HMT |
Histone methyltransferase |
KDM |
Lysine demethylase |
LOX |
Lysyl oxidase |
MI |
Myocardial infarction |
MMP |
Matrix metalloproteinase |
MRA |
Mineralocorticoid receptor antagonist |
PDGF |
Platelet-derived growth factor |
RAAS |
Renin-angiotensin-aldosterone system |
ROS |
Reactive oxygen species |
SAM |
S-adenosylmethionine |
scRNA-seq |
Single-cell RNA sequencing |
TF |
Transcription factor |
TGF-β |
Transforming growth factor beta |